Biological Activity of Amidino-Substituted Imidazo [4,5- b]pyridines

Molecules. 2022 Dec 21;28(1):34. doi: 10.3390/molecules28010034.

Abstract

A series of cyano- and amidino-substituted imidazo[4,5-b]pyridines were synthesized using standard methods of organic synthesis, and their biological activity was evaluated. Biological evaluation included in vitro assessment of antiproliferative effects on a diverse selection of human cancer cell lines, antibacterial activity against chosen Gram-positive and Gram-negative bacterial strains, and antiviral activity on a broad panel of DNA and RNA viruses. The most pronounced antiproliferative activity was observed for compound 10, which contained an unsubstituted amidino group, and compound 14, which contained a 2-imidazolinyl amidino group; both displayed selective and strong activity in sub-micromolar inhibitory concentration range against colon carcinoma (IC50 0.4 and 0.7 μM, respectively). All tested compounds lacked antibacterial activity, with the exception of compound 14, which showed moderate activity against E. coli (MIC 32 μM). Bromo-substituted derivative 7, which contained an unsubstituted phenyl ring (EC50 21 μM), and para-cyano-substituted derivative 17 (EC50 58 μM) showed selective but moderate activity against respiratory syncytial virus (RSV).

Keywords: amidines; antibacterial activity; antiproliferative activity; antiviral activity; imidazo[4,5-b]pyridines.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Antineoplastic Agents* / pharmacology
  • Cell Line, Tumor
  • Cell Proliferation
  • Escherichia coli
  • Humans
  • Pyridines* / pharmacology
  • Structure-Activity Relationship

Substances

  • Pyridines
  • Antineoplastic Agents
  • Anti-Bacterial Agents